Coiled-Coil Based Inclusion Bodies and Their Potential Applications.

biomaterials biomedicine biotechnology coiled-coil functional inclusion bodies protein assembly tags

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2021
Historique:
received: 30 06 2021
accepted: 05 08 2021
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 7 9 2021
Statut: epublish

Résumé

The production of recombinant proteins using microbial cell factories is frequently associated with the formation of inclusion bodies (IBs). These proteinaceous entities can be sometimes a reservoir of stable and active protein, might display good biocompatibility, and are produced efficiently and cost-effectively. Thus, these submicrometric particles are increasingly exploited as functional biomaterials for biotechnological and biomedical purposes. The fusion of aggregation-prone sequences to the target protein is a successful strategy to sequester soluble recombinant polypeptides into IBs. Traditionally, the use of these IB-tags results in the formation of amyloid-like scaffolds where the protein of interest is trapped. This amyloid conformation might compromise the protein's activity and be potentially cytotoxic. One promising alternative to overcome these limitations exploits the coiled-coil fold, composed of two or more α-helices and widely used by nature to create supramolecular assemblies. In this review, we summarize the state-of-the-art of functional IBs technology, focusing on the coiled-coil-assembly strategy, describing its advantages and applications, delving into future developments and necessary improvements in the field.

Identifiants

pubmed: 34485264
doi: 10.3389/fbioe.2021.734068
pii: 734068
pmc: PMC8415879
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

734068

Informations de copyright

Copyright © 2021 Gil-Garcia and Ventura.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nanomedicine (Lond). 2015;10(18):2881-91
pubmed: 26370294
Microb Cell Fact. 2020 Jun 5;19(1):122
pubmed: 32503648
PLoS Biol. 2008 Aug 5;6(8):e195
pubmed: 18684013
FEMS Microbiol Rev. 2019 Jan 1;43(1):53-72
pubmed: 30357330
Front Immunol. 2018 Jul 18;9:1652
pubmed: 30072996
Sci Rep. 2018 Sep 17;8(1):13917
pubmed: 30224788
Sci Rep. 2018 Apr 11;8(1):5856
pubmed: 29643457
Trends Biochem Sci. 2017 Feb;42(2):130-140
pubmed: 27884598
Microb Cell Fact. 2008 Dec 01;7:34
pubmed: 19046444
Front Bioeng Biotechnol. 2020 Jan 10;7:442
pubmed: 31998707
Microb Cell Fact. 2014 Sep 12;13:137
pubmed: 25213001
J Mol Biol. 2005 Apr 15;347(5):1025-37
pubmed: 15784261
Open Biol. 2015 Feb;5(2):140221
pubmed: 25673330
Adv Sci (Weinh). 2019 Nov 27;7(3):1902420
pubmed: 32042562
J Biosci Bioeng. 2020 Jun;129(6):730-740
pubmed: 32143998
Microb Cell Fact. 2020 Jun 1;19(1):117
pubmed: 32487230
Chembiochem. 2011 Feb 11;12(3):407-23
pubmed: 21290543
Microb Cell Fact. 2012 May 03;11:55
pubmed: 22553999
J Biotechnol. 2008 Nov 25;138(3-4):67-73
pubmed: 18760314
Trends Biotechnol. 2006 Apr;24(4):179-85
pubmed: 16503059
Microb Cell Fact. 2015 Mar 25;14:41
pubmed: 25889252
Science. 2009 Jul 17;325(5938):328-32
pubmed: 19541956
J Biotechnol. 2017 Sep 20;258:136-147
pubmed: 28465211
Microb Cell Fact. 2018 Sep 3;17(1):139
pubmed: 30176877
Int J Mol Sci. 2021 Mar 16;22(6):
pubmed: 33809594
Biotechnol Bioeng. 2007 Jun 15;97(3):454-61
pubmed: 17089401
Biomaterials. 2016 Nov;107:102-14
pubmed: 27614162
J Chromatogr A. 2006 Jul 7;1120(1-2):158-64
pubmed: 16387315
Nanomedicine (Lond). 2012 Jan;7(1):79-93
pubmed: 22142409
Microb Cell Fact. 2016 Feb 09;15:33
pubmed: 26861699
Adv Sci (Weinh). 2019 Jul 24;6(18):1900849
pubmed: 31559131
Biotechnol Prog. 2005 Mar-Apr;21(2):632-9
pubmed: 15801811
ACS Synth Biol. 2018 Sep 21;7(9):2282-2295
pubmed: 30053372
Aust J Biotechnol. 1989 Jan;3(1):28-32
pubmed: 2485330
Adv Drug Deliv Rev. 2021 Mar;170:26-43
pubmed: 33378707
Mol Microbiol. 2006 Oct;62(2):427-37
pubmed: 17020581
Cell Mol Immunol. 2020 Apr;17(4):415-417
pubmed: 31595053
FEBS J. 2006 Feb;273(3):658-68
pubmed: 16420488
Trends Biotechnol. 2014 Jul;32(7):372-80
pubmed: 24908382
ACS Nano. 2013 Jun 25;7(6):4774-84
pubmed: 23705583
Appl Microbiol Biotechnol. 2020 Sep;104(17):7313-7329
pubmed: 32651598
Nat Biotechnol. 2018 Dec 6;36(12):1136-1145
pubmed: 30520869
Microb Cell Fact. 2016 Oct 1;15(1):166
pubmed: 27716225
FEBS Lett. 2006 Nov 27;580(27):6471-6
pubmed: 17101131
Acta Biomater. 2014 Mar;10(3):1354-9
pubmed: 24361427
Nanomedicine (Lond). 2013 Oct;8(10):1587-99
pubmed: 23394133
Microb Cell Fact. 2017 Mar 21;16(1):50
pubmed: 28320377
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Mar;9(2):
pubmed: 27597649
Structure. 2010 Mar 14;18(4):436-48
pubmed: 20399181
FEBS Lett. 1991 Apr 22;282(1):205-8
pubmed: 2026260
Microb Cell Fact. 2015 Jun 16;14:88
pubmed: 26077447
Microb Cell Fact. 2020 Sep 4;19(1):175
pubmed: 32887587
Biotechnol J. 2011 Jun;6(6):752-60
pubmed: 21538899
Front Microbiol. 2014 Feb 19;5:63
pubmed: 24600443
Bioessays. 2016 Sep;38(9):903-16
pubmed: 27492088
Biomacromolecules. 2020 Jun 8;21(6):2334-2345
pubmed: 32227922
Trends Biotechnol. 2020 May;38(5):474-486
pubmed: 31954528
Adv Mater. 2020 Feb;32(7):e1907348
pubmed: 31879981
Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):1015-1020
pubmed: 31892536
Trends Biochem Sci. 2007 May;32(5):204-6
pubmed: 17419062
Nat Biotechnol. 2017 Nov;35(11):1094-1101
pubmed: 29035374
PLoS One. 2010 Feb 25;5(2):e9383
pubmed: 20195530
Nanotechnology. 2010 May 21;21(20):205101
pubmed: 20413834
Nat Biotechnol. 2004 Nov;22(11):1399-408
pubmed: 15529165
J Am Chem Soc. 2013 Oct 16;135(41):15565-78
pubmed: 24028069
Anal Biochem. 2012 Jul 1;426(1):63-5
pubmed: 22490467
Microb Cell Fact. 2019 Feb 7;18(1):33
pubmed: 30732596
Mol Pharm. 2018 Sep 4;15(9):3846-3859
pubmed: 30036481
Biotechnol Lett. 2003 Sep;25(17):1385-95
pubmed: 14514038
Microb Cell Fact. 2011 Feb 15;10:9
pubmed: 21320350
Nat Struct Biol. 2000 Sep;7(9):772-6
pubmed: 10966648
Appl Microbiol Biotechnol. 2014 Nov;98(22):9229-38
pubmed: 25129611
Mol Microbiol. 2008 May;68(3):720-35
pubmed: 18394147
J Control Release. 2018 Jun 10;279:29-39
pubmed: 29641987
Int J Biol Macromol. 2018 Mar;108:826-836
pubmed: 29101045
PLoS One. 2016 Oct 7;11(10):e0164073
pubmed: 27716780
Protein Sci. 2019 Sep;28(9):1620-1629
pubmed: 31278804
Trends Biotechnol. 2012 Feb;30(2):65-70
pubmed: 22037492
Biochim Biophys Acta. 2008 Oct;1783(10):1815-25
pubmed: 18619498
Biotechnol Biotechnol Equip. 2015 Mar 4;29(2):205-220
pubmed: 26019635
Microb Cell Fact. 2005 Sep 12;4:27
pubmed: 16156893
Adv Mater. 2012 Apr 3;24(13):1742-7
pubmed: 22410789
Acta Biomater. 2013 Apr;9(4):6134-42
pubmed: 23220450
J Control Release. 2020 Nov 10;327:61-69
pubmed: 32768629
Adv Funct Mater. 2019 Feb 21;29(8):1807357
pubmed: 32313545

Auteurs

Marcos Gil-Garcia (M)

Institut de Biotecnologia i de Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Salvador Ventura (S)

Institut de Biotecnologia i de Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Classifications MeSH